Latest News
TELA Bio, Inc.
- TELA Bio, Inc. Estimates – BOATS:TELA
- Form 4 Tela Bio Inc: Joseph H. Capper (Director) For: 15 October
- Stock replaces cash pay for TELA Bio (TELA) director in 19,801-share award.
- TELA Bio (TELA) director William J. Plovanic receives 16,089 shares instead of cash compensation.
- Malvern’s TELA Bio Receives FDA 510(k) Clearance for Liora™ Monofilament Scaffold, Its First In-House Developed Implant
- TELA Bio Q2 2026 Earnings: Wider-Than-Expected Loss Weighs on Shares - Cash Flow Report
- TELA Bio gains FDA clearance for Liora scaffold
- TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
- TELA Bio Receives FDA 510(k) Clearance for Liora Monofilament Scaffold, Expanding Soft-Tissue Reconstruction Portfolio
Headlines from the last 30 days, linking to the original publishers. See all market news →